文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Jialei Wang
发表
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: Primary results from the phase 3 MARIPOSA-2 study.
R. Knoblauch, R. Gentzler, M. Mackean, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.